Rafik Terra
Montreal, QC H1T2M4, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
From Chronic Lymphocytic Leukemia to Plasmablastic Myeloma: Beyond the Usual Richter Transformation.
From Chronic Lymphocytic Leukemia to Plasmablastic Myeloma: Beyond the Usual Richter Transformation.
Journal: Current oncology (Toronto, Ont.)
Published: August 26, 2025
Prognostic value and kinetic patterns of measurable residual disease following tandem autologous/allogeneic transplant in newly diagnosed myeloma patients.
Journal: Bone marrow transplantation
Published: March 20, 2025
A Phase II, Open-Label Study of Lenalidomide and Dexamethasone Followed by Donor Lymphocyte Infusions in Relapsed Multiple Myeloma Following Upfront Allogeneic Stem Cell Transplant.
Journal: Current oncology (Toronto, Ont.)
Published: September 20, 2024
A Pilot Study of UM171-Expanded Cord Blood Grafts for Tandem Auto/Allogeneic Hematopoietic Cell Transplant in High and Ultra-High-Risk Myeloma Patients.
Journal: Transplantation and cellular therapy
Published: July 07, 2024
Improved identification of clinically relevant Acute Leukemia subtypes using standardized EuroFlow panels versus non-standardized approach.
Journal: Cytometry. Part B, Clinical cytometry
Published: June 15, 2024
Outcomes in newly diagnosed young or high-risk myeloma patients receiving tandem autologous/allogeneic transplant followed by bortezomib maintenance: a phase II study.
Journal: Bone marrow transplantation
Published: August 29, 2021
To investigate the necessity of STRA6 upregulation in T cells during T cell immune responses.
Journal: PloS one
Published: September 28, 2013
Efnb1 and Efnb2 proteins regulate thymocyte development, peripheral T cell differentiation, and antiviral immune responses and are essential for interleukin-6 (IL-6) signaling.
Journal: The Journal of biological chemistry
Published: October 07, 2011
Showing 1-8 of 8
Last Updated: 09/26/2026